OBRENZA 150 Tablet 60’s

Description

OBRENZA 150 Tablet is an anticancer medicine used in carefully selected patients to help treat certain cancers that have specific genetic changes, especially cancers linked to defects in dna repair pathways. it belongs to a class of medicines known as parp inhibitors. parp stands for poly(adp-ribose) polymerase, an enzyme that helps cells repair damaged dna. cancer cells often divide rapidly and depend heavily on dna repair systems to survive. by blocking parp, OBRENZA 150 Tablet interferes with the cancer cell’s ability to fix its dna, which can lead to cell death and slow the growth or spread of the tumor.

this medicine is most commonly used in cancers where the tumor has inherited or acquired problems in dna repair genes, such as brca-related changes, although the exact use depends on the cancer type and the patient’s test results. because it works differently from traditional chemotherapy, OBRENZA 150 Tablet may be used alone or in combination with other cancer treatments in certain situations. it is not a general cancer medicine for all tumors; its benefit is greatest when the cancer has the biological features that make it sensitive to parp inhibition.

OBRENZA 150 Tablet is prescribed for specific cancers under close specialist supervision, including some ovarian, breast, pancreatic, and prostate cancers, depending on approved indications in a given country and the patient’s medical profile. it is usually part of a long-term treatment plan and requires regular monitoring of blood counts, symptoms, and treatment response. since it can cause important side effects and interacts with several medicines, it should be taken only under the guidance of an oncologist or other qualified healthcare professional.

ingredients

• OBRENZA 150 Tablet: this is the active ingredient and the main anticancer component. it blocks the parp enzyme, which cancer cells use to repair damaged dna. by preventing repair, OBRENZA 150 Tablet increases dna damage inside vulnerable cancer cells, helping stop their growth and promoting cell death.
• tablet or capsule excipients: the formulation may contain inactive ingredients such as fillers, binders, coating agents, and stabilizers that help maintain the medicine’s shape, stability, absorption, and shelf life. these ingredients do not treat cancer but are important for proper drug delivery.

key uses

• ovarian cancer: OBRENZA 150 Tablet is used in certain ovarian, fallopian tube, or primary peritoneal cancers, especially when there is a brca mutation or another feature showing defective dna repair. it may be used as maintenance therapy after response to initial treatment or in some recurrent cases.
• breast cancer: in selected patients with her2-negative breast cancer and inherited brca changes, OBRENZA 150 Tablet may help control disease progression. it is generally considered when the cancer has spread or returned and is sensitive to dna repair inhibition.
• pancreatic cancer: in some people with metastatic pancreatic cancer and inherited brca mutations, OBRENZA 150 Tablet may be used to help delay progression after the disease has responded to platinum-based chemotherapy.
• prostate cancer: OBRENZA 150 Tablet may be used in certain advanced prostate cancers with hrr gene alterations, including brca and related dna repair gene defects. it can be beneficial when standard hormone-based treatments are no longer sufficient.
• maintenance treatment after response to prior therapy: in some cancer types, OBRENZA 150 Tablet is used to maintain remission or slow recurrence after the tumor has responded to initial chemotherapy or other treatment. this helps prolong the time before the cancer grows again.

how to use

OBRENZA 150 Tablet should be taken exactly as directed by the prescribing oncologist. the medicine is usually taken by mouth on a regular schedule, with or without food, depending on the specific product instructions. it is important to swallow the tablets or capsules whole unless a healthcare professional has given different instructions. do not crush, split, chew, or open the medicine if this is not allowed for your formulation, because that may affect how the drug is absorbed and increase the risk of side effects.

try to take OBRENZA 150 Tablet at the same times each day to keep a steady level in the body. if the dose is missed, follow the instructions provided by your healthcare team or pharmacist, rather than doubling up on your own. because this medicine is used for serious cancers and can affect blood counts and other body systems, regular blood tests and follow-up appointments are important. your doctor may adjust treatment based on tolerance, laboratory results, and how well the cancer is responding. never stop or change the dose without medical advice.

safety information

• warnings: OBRENZA 150 Tablet can lower blood cell counts, including red cells, white cells, and platelets, which may cause fatigue, infection risk, or bleeding. it can also cause nausea, vomiting, diarrhea, decreased appetite, and tiredness. in rare cases, serious blood disorders such as myelodysplastic syndrome or acute myeloid leukemia have been reported. seek urgent medical help for fever, unusual bruising, shortness of breath, severe weakness, or signs of infection.
• side effects: common side effects include nausea, vomiting, diarrhea, constipation, indigestion, abdominal pain, loss of appetite, headache, dizziness, tiredness, and changes in blood counts. serious side effects may include severe anemia, low white blood cells, low platelets, lung inflammation or interstitial lung disease, serious allergic reactions, and secondary blood cancers. any new or worsening cough, breathlessness, chest discomfort, or persistent fever should be reported promptly.
• precautions: use extra caution if you have current or previous bone marrow problems, reduced blood counts, kidney or liver disease, lung disease, or a history of serious drug reactions. OBRENZA 150 Tablet may not be appropriate for everyone, especially if blood tests are already abnormal. older adults may be more sensitive to side effects. tell your healthcare provider about all cancers, prior therapies, and genetic test results before starting treatment.
• pregnancy/breastfeeding: OBRENZA 150 Tablet can harm an unborn baby and is generally not recommended during pregnancy. people who can become pregnant should use effective contraception during treatment and for the period recommended by the prescriber after the last dose. breastfeeding is usually not advised during treatment and for some time afterward because it is not known whether the medicine passes into breast milk and may affect the infant.
• interactions: OBRENZA 150 Tablet may interact with medicines that affect liver enzymes, especially strong cyp3a inhibitors or inducers, which can raise or lower OBRENZA 150 Tablet levels. this includes some antifungals, antibiotics, seizure medicines, and hiv medicines. grapefruit and grapefruit juice may also interfere with metabolism and should generally be avoided unless your healthcare team says otherwise. alcohol may worsen nausea, dizziness, and stomach upset, so it should be used cautiously or avoided depending on your condition.

additional information

• storage: store OBRENZA 150 Tablet at room temperature in a dry place away from excess heat, moisture, and direct light. keep it in the original container with the lid tightly closed. do not store it in the bathroom. keep all cancer medicines out of reach of children and pets.
• missed dose: if you miss a dose, take it only if it is close to the scheduled time and your prescriber’s instructions allow it. if it is nearly time for the next dose, skip the missed dose and return to the regular schedule. do not take two doses at once unless your healthcare professional specifically instructs you to do so.
• overdose: taking too much OBRENZA 150 Tablet may increase the risk of severe nausea, vomiting, weakness, dizziness, and dangerous blood count suppression. if an overdose is suspected, contact emergency services, a poison center, or a healthcare professional right away. do not wait for symptoms to appear, because some effects may be delayed and serious.
• habit forming: no. OBRENZA 150 Tablet is not known to be habit forming or addictive. however, it is an important long-term cancer therapy that should not be stopped suddenly without medical guidance because doing so may affect treatment outcomes.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.